SYN117 (nepicastat) + Placebo comparator
Phase 2Withdrawn 0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post Traumatic Stress Disorder (PTSD)
Conditions
Post Traumatic Stress Disorder (PTSD)
Trial Timeline
Jun 1, 2008 → Nov 1, 2009
NCT ID
NCT00641511About SYN117 (nepicastat) + Placebo comparator
SYN117 (nepicastat) + Placebo comparator is a phase 2 stage product being developed by Johnson & Johnson for Post Traumatic Stress Disorder (PTSD). The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00641511. Target conditions include Post Traumatic Stress Disorder (PTSD).
What happened to similar drugs?
20 of 20 similar drugs in Post Traumatic Stress Disorder (PTSD) were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
12
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00641511 | Phase 2 | Withdrawn |
Competing Products
20 competing products in Post Traumatic Stress Disorder (PTSD)